CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)
Clinical trial NCT03408587 · COMPLETED
Trial details
- NCT number
- NCT03408587
- Sponsor
- Viralytics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2019-05-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.